Identifying Patients at High Risk of COVID-19 Complications: Considerations for Community Care to Reduce Morbidity, Mortality, and Hospitalization Risk
Released On
February 1, 2023
Expires On
January 31, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Primary Care, Pediatrics, Internal Medicine, Family Practice
Topic(s)
COVID
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Med Learning Group.
This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM)
This activity is supported by an educational grant from Pfizer.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Resources:
Poster Portal
Case Study 1
Case Study 2
Target Audience
This activity is designed to meet the educational needs of primary care physicians, internists, pharmacists, nurses, nurse practitioners, physician assistants, and other members of the multidisciplinary team to ensure optimal patient outcomes in outpatient management of COVID-19 infection and potential complications of disease in at-risk populations.
Program Overview
This program uses a game-based approach to explore the current understanding of COVID risk assessment, diagnosis, and outpatient treatment.
Learning Objectives
Upon completion of the program, attendees should be able to:
- Assess current best practices in the identification of patients in the community setting at risk of developing serious complications following COVID-19 infection
- Evaluate specific interventions for reducing the risk of hospitalization and death in at-risk non-hospitalized patients with COVID-19 infection
- Review clinical guidance regarding appropriate treatment strategies in non-hospitalized patients at risk of serious complications of COVID-19
Faculty
Ann E. Woolley, MD, MPH
Associate Clinical Director of Transplant Infectious Diseases
Brigham and Women’s Hospital and Harvard Medical School
Boston, MA
Ann Ellis Woolley, MD, MPH, focuses on innovation in the care of solid organ and bone marrow transplant recipients with infectious disease complications in the Brigham and Women’s Hospital (BWH) and Dana Farber Cancer Institute at Harvard Medical School. She is the Associate Clinical Director of Solid Organ Transplant Infectious Diseases at BWH, an Affiliated Scientist at the Broad Institute, and Associate Medical Director for the New England Donor Services.
Dr. Woolley received her BSE degree from Princeton University in mechanical and aerospace engineering, MD, and MPH degrees from the Icahn School of Medicine at Mount Sinai in New York, and internal medicine and chief residency at Boston Medical Center, and her infectious disease fellowship at the Harvard Partners Program at Massachusetts General Hospital and BWH with a subspecialty within infectious diseases in the immunocompromised host, primarily oncology patients and recipients of solid organ and hematopoietic stem cell transplants.
Dr. Woolley is a clinical investigator in human studies, including the identification of infectious disease syndromes and in the development of novel diagnostics and therapeutics. She is currently leading clinical trials focused on the impact of infection in organ transplantation in an effort to expand the organ donor pool and minimize infectious complications post-transplantation. In addition, she has a clinical expertise in the management of COVID-19 and leads several COVID-19 diagnostic and therapeutic clinical trials.
Physician Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in this enduring activity.
Nursing Credit Designation
Purpose: This program would be beneficial for nurses involved in the care of patients with COVID-19.
CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosures of Conflicts of Interest
Ann E. Woolley, MD, MPH, has nothing to disclose.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, has nothing to disclose.
Debra Gordon, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
Rashado Coote, Program Coordinator, has nothing to disclose.
Method of Participation
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Complete the online post-test and evaluation
You will receive your certificate as a downloadable file.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com
Content - Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
